OneCell Diagnostics Inc.’s Post

OneCell Diagnostics Inc., a genomics-based precision oncology company based in Cupertino, CA, and Mumbai, India, raised $16M in Series A Funding. Celesta Capital led the round, which also included Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures. Celesta Capital Founding Managing Partner Michael Marks and Nobel Laureate and Celesta Capital Senior Advisor Dr. James Rothman will join the OneCell board of directors. https://lnkd.in/geXnqcqn